1. Li Z, Jiang H, Ding T*, Lou C, Bui HH, Kuo MS, Jiang XC.Deficiency in Lysophosphatidylcholine Acyltransferase 3 Reduces Plasma Levels of Lipids by Reducing Lipid Absorption in Mice.Gastroenterology. 2015 Jul 27. pii: S0016-5085(15)01006-9. doi: 10.1053（IF 16.716）
2. Ding T*, Kabir I, Li Y, Lou C, Yazdanyar A, Xu J, Dong J, Zhou H, Park T, Boutjdir M, Li Z, Jiang XC.All members in the sphingomyelin synthase gene family have ceramide phosphoethanolamine synthase activity.J Lipid Res. 2015 Mar;56(3):537-45.（IF4.421）
3. Li Y, Dong J, Ding T*, Kuo MS, Cao G, Jiang XC, Li Z.Sphingomyelin synthase 2 activity and liver steatosis: an effect of ceramide-mediated peroxisome proliferator-activated receptor γ2 suppression.ArteriosclerThrombVasc Biol. 2013 Jul;33(7):1513-20.（IF5.533）
4. Li Z, Ding T*, Pan X, Li Y, Li R, Sanders PE, Kuo MS, Hussain MM, Cao G, Jiang XC.Lysophosphatidylcholine acyltransferase 3 knockdown-mediated liver lysophosphatidylcholine accumulation promotes very low density lipoprotein production by enhancing microsomal triglyceride transfer protein expression.J Biol Chem. 2012 Jun 8;287(24):20122-31.（IF4.651）
5. Ding T*, Li Z, Hailemariam T, Mukherjee S, Maxfield FR, Wu MP, Jiang XC.SMS overexpression and knockdown: impact on cellular sphingomyelin and diacylglycerol metabolism, and cell apoptosis.J Lipid Res. 2008 Feb;49(2):376-85.（IF4.368）
6. Deng X, Lin F, Zhang Y, Li Y, Zhou L, Lou B, Li Y, Dong J, Ding T*, Jiang X, Wang R, Ye D.Identification of small molecule sphingomyelin synthase inhibitors.. 2014 Feb 12;73:1-7. (IF 3.447)